Comparative analysis of pathogen structure in patients with PJI after primary total hip and knee arthroplasty

Petr Preobrazhensky1, Svetlana Bozhkova2, Andrey Kochish2

  • 1Vreden National Research Center of Traumatology and Orthopaedics of the Ministry of Health of Russian Federation, Akademika Baikova Str., 8, St. Petersburg, Russian Federation, 195427. Pedrro@yandex.ru.

Abstract

Insights

Peripiprosthetic joint infection (PJI) pathogen profiles differ between hip and knee replacements. Understanding these differences, particularly polymicrobial infections, is crucial for effective treatment strategies and antibiotic selection in PJI management.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Microbiology

Background:

  • Peripiprosthetic joint infection (PJI) is a severe complication following total hip (THA) and knee (TKA) arthroplasty.
  • The microbiological landscape of PJI varies geographically and institutionally.
  • Identifying pathogen profiles is key to optimizing treatment outcomes.

Purpose of the Study:

  • To analyze the specific pathogen structures in hip and knee PJI.
  • To compare the microbial profiles between hip and knee PJI cases.
  • To evaluate the influence of pathogen structure on the success of two-stage reimplantation for PJI.

Main Methods:

  • Retrospective analysis of 364 patients with PJI after primary THA or TKA from 2012-2017.
  • Patients were treated with a two-stage reimplantation protocol.
  • Comparative analysis of pathogen prevalence and subanalysis based on treatment success.

Main Results:

  • Staphylococcus epidermidis was the most common pathogen in both hip and knee PJI.
  • Methicillin-resistant Staphylococcus epidermidis (MRSE) was more prevalent in hip PJI (50%) than knee PJI (35%).
  • Polymicrobial infections were significantly more common in hip PJI (45.3%) versus knee PJI (14%), increasing recurrence risk in knee PJI.

Conclusions:

  • Significant differences exist in the microbiological profiles of hip and knee PJI.
  • These distinct pathogen structures necessitate tailored treatment strategies.
  • Findings inform the selection of empirical antibiotic regimens for PJI management.